PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
about
Update on Immunohistochemistry for the Diagnosis of Lung Cancer.Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report.Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity.Standardized Uptake Values Derived from 18F-FDG PET May Predict Lung Cancer Microvessel Density and Expression of KI 67, VEGF, and HIF-1α but Not Expression of Cyclin D1, PCNA, EGFR, PD L1, and p53.Expression of TRPM8 in human reactive lymphoid tissues and mature B-cell neoplasmsPresence of few PD-1-expressing tumor-infiltrating immune cells is a potential predictor of improved response to salvage chemotherapy following nivolumab for non-small cell lung cancer: An exploratory case series
P2860
PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
@en
PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
@nl
type
label
PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
@en
PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
@nl
prefLabel
PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
@en
PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
@nl
P2860
P1433
P1476
PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
@en
P2093
Nathalie Labarriere
Sylvain Simon
P2860
P304
P356
10.1080/2162402X.2017.1364828
P577
2017-09-14T00:00:00Z